SM Spine Developments Ltd Filleted accounts for Companies House (small and micro)

COMPANY REGISTRATION NUMBER: 08514662

SM Spine Developments Ltd

Filleted Unaudited Financial Statements

30 November 2025

SM Spine Developments Ltd

Statement of Financial Position

30 November 2025

	2025	2024
Note	£	£

Fixed assets

Investments	5	95	95

Current assets

Debtors	6	313,383	61,752
Cash at bank and in hand		112,891	389,611
		---------	---------
		426,274	451,363

Creditors: amounts falling due within one year	7	19,568	60,675
		---------	---------
Net current assets		406,706	390,688
		---------	---------
Total assets less current liabilities		406,801	390,783
		---------	---------
Net assets		406,801	390,783
		---------	---------

Capital and reserves

Called up share capital	61	61
Profit and loss account	406,740	390,722
	---------	---------
Shareholders funds	406,801	390,783
	---------	---------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.

For the year ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;

- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

SM Spine Developments Ltd

Statement of Financial Position (continued)

30 November 2025

These financial statements were approved by the board of directors and authorised for issue on 21 August 2026 , and are signed on behalf of the board by:

Dr S Molloy
Director

Company registration number: 08514662

SM Spine Developments Ltd

Notes to the Financial Statements

Year ended 30 November 2025

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is C/O Leaman Mattei, Suite 1, First Floor, 1 Duchess Street, London, W1W 6AN.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered and stated net of discounts.

Income tax

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

	Plant and machinery	-	10% straight line

Investments

Fixed asset investments are initially recorded at cost, and subsequently stated at cost less any accumulated impairment losses.

Financial instruments

A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

4. Tangible assets

	Plant and machinery
	£
Cost
At 1 December 2024 and 30 November 2025	138,240
	---------
Depreciation
At 1 December 2024 and 30 November 2025	138,240
	---------
Carrying amount
At 30 November 2025	–
	---------
At 30 November 2024	–
	---------

5. Investments

	Shares in group undertakings
	£
Cost
At 1 December 2024 and 30 November 2025	95
	----
Impairment
At 1 December 2024 and 30 November 2025	–
	----

Carrying amount
At 30 November 2025	95
	----
At 30 November 2024	95
	----

6. Debtors

	2025	2024
	£	£
Other debtors	313,383	61,752
	---------	--------

7. Creditors: amounts falling due within one year

	2025	2024
	£	£
Corporation tax	4,075	46,915
Other creditors	15,493	13,760
	--------	--------
	19,568	60,675
	--------	--------

8. Director's advances, credits and guarantees

During the year the director entered into the following advances and credits with the company:

	2025
	Balance brought forward	Advances/ (credits) to the director	Amounts repaid	Balance outstanding
	£	£	£	£
Dr S Molloy	–	351,631	( 100,000)	251,631
	----	---------	---------	---------

	2024
	Balance brought forward	Advances/ (credits) to the director	Amounts repaid	Balance outstanding
	£	£	£	£
Dr S Molloy	182,968	–	( 182,968)	–
	---------	----	---------	----

9. Related party transactions

Sean Molloy Limited is a related party of SM Spine Developments Limited due to the company being under the control of the director. During the year Sean Molloy Limited provided loans of £2,430 to SM Spine Developments Limited. The amount due to Sean Molloy Limited at 30 November 2025 is £12,823 (2024: £10,393). The loan is interest free and repayable on demand.